Cantel Medical (CMD) Stock Analyst Ratings
NYSEARCA:CMD - NYSE Arca -
ChartMill assigns a Buy % Consensus number of 65% to CMD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 63.24. This target is -21.31% below the current price.
CMD was analyzed by 4 analysts. The buy percentage consensus is at 65. So analysts seem to be rather neutral about CMD.
In the previous month the buy percentage consensus was at a similar level.
Only 4 analysts analyzed CMD. So this is just the average opinion of a couple of analysts.